Too Much Sleep Is Just As Dangerous As Too Little Sleep in Developing Gestational Diabetes

Article

Everyone needs an adequate amount of sleep every night, but it should especially be a priority in pregnant women. However, there is a fine line between too much and too little sleep, but either way, both sides of the spectrum have an increase risk in gestational diabetes.

endocrinology, diabetes, gestational diabetes, OBGYN, women’s health, pregnant, pregnancy, sleep, napping, American Diabetes Association, ADA 2016

Everyone needs an adequate amount of sleep every night, but it should especially be a priority in pregnant women. However, there is a fine line between too much and too little sleep, but either way, both sides of the spectrum have an increase risk in gestational diabetes.

Presented at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana, a new study found that there is an important risk between sleep and risk of developing gestational diabetes.

Unfortunately, sleep problems aren’t exactly uncommon in pregnant women. However, catching enough Z’s plays an important role in having type 2 diabetes later in life. Researchers from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) aimed to find the link between the condition and sleep on a trimester-specific basis.

Using a multiracial cohort of 2,334 non-obese and 468 obese pregnant women, the researchers studied a total of 2,581 of them. The women reported their sleep habits during their first trimester (weeks eight to 13) and second trimester (weeks 16 to 22). The durations of overnight sleep were grouped by: five to six hours, seven hours, eight to nine hours, and 10 or more hours. Napping frequency was also taken into account and categorized by: most times, sometimes, and rarely or never.

  • MD Magazine is on Facebook, Twitter, Instagram, and LinkedIn!

A total of 103 participants developed gestational diabetes.

The amount of women sleeping for 10 or more hours decreased from first to second trimester (24.4% vs. 14.7%). Napping sometimes or most times also decreased (80.4% vs. 54.4%). Sleep during the first trimester did not have an independent impact on the gestational diabetes. However, sleep had a significant effect during the second trimester.

Compared to women who slept eight to nine hours and rarely or never napped, those who slept five to seven hours and did not nap had a 2.65 adjusted relative risk (ARR) of developing gestational diabetes. Women who slept eight to nine hours and napped sometimes or most times had a 2.07 ARR and those who slept for 10 hours or more and napped had a 2.24 ARR.

“Only among non-obese women, sleeping more or less than eight to nine hours were both significantly related to gestational diabetes risk,” the authors explained. The ARRs were 2.53 for five to six hours, 1.98 for seven hours, and 2.37 for 10 hours.

Therefore, getting too much sleep is just as risky as getting too little sleep when it comes to gestational diabetes, and napping and obesity can contribute to that risk.

Also on MD Magazine >>> More News from ADA 2016 in New Orleans

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Phase 2 Data Shows KP1077 Meaningfully Improves Idiopathic Hypersomnia Symptoms
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.